ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Planmeca Expands AI Capabilities with Pearl Integration

Pearl and Planmeca partner to bring enhanced AI-based image analysis services to Planmeca Romexis users

Pearl, the global leader in dental AI solutions, and Planmeca, the world's largest privately-owned dental equipment manufacturer, today announced plans to integrate Pearl’s Second Opinion® disease detection capabilities within Planmeca’s robust imaging software platform, Planmeca Romexis®.

“AI is primed to revolutionize the global dentistry market, and together with Planmeca Romexis®, we’re expanding access to the powerful capabilities of this technology,” said Ophir Tanz, founder and CEO of Pearl. “Our partnership with Planmeca will seamlessly integrate Second Opinion® into one of the most popular, powerful and technologically advanced imaging platforms in dentistry, streamlining clinical efficiencies and steering the industry towards a fully AI-powered future.”

Second Opinion® is the first-and-only chairside AI software with global regulatory clearances to assist dentists in the detection of numerous common conditions in bitewing, periapical and panoramic x-rays of adult teeth in patients as young as 12 years old. For Romexis users, Second Opinion® software will provide AI evaluations of 2D intraoral X-ray images directly within the Romexis platform, facilitating streamlined patient communication, enhanced diagnostic capabilities and a higher standard of dental care delivery. The integration will be available for Romexis users around the world soon.

“We are deeply committed to delivering the most advanced capabilities in digital imaging to dental clinics of all sizes and specialties,” said Helianna Puhlin-Nurminen, Vice President of Digital Imaging and Applications at Planmeca. “This collaboration with Pearl will further augment diagnostic consistency, accuracy and transparency in dental care, equipping Romexis users with the most advanced pathology detection and patient communication technology.”

About Pearl

Pearl is leading the global dental AI revolution with groundbreaking computer vision solutions that elevate efficiency, accuracy, and the standard of care in dentistry. Founded in 2019 by Ophir Tanz, Pearl is backed by Craft Ventures and other leading venture capital firms. To request a demonstration, please visit hellopearl.com/demo.

About Planmeca USA

Planmeca is one of the world's leading dental equipment manufacturers, with a product range covering digital dental units, CAD/CAM solutions, world-class 2D and 3D imaging devices and comprehensive software solutions. Privately owned and headquartered in Helsinki, Finland, the company offers a portfolio of high-tech products distributed in over 120 countries worldwide. For more information, visit planmeca.com.

Contacts

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.